Press Releases
Alma Lasers Inc., receives new FDA clearance soprano ICE...
Alma Lasers, a subsidiary of Sisram Medical Ltd , the leading global innovator of laser light-based, radio frequency and ultrasound solutions for the aesthetic and...
Press Releases
Study claims the Importance of familiarizing the risks and...
On average, 1 in 10 children who enroll in pediatric phase I cancer trials are improved after the trial, and 1 in 50 die from...
Press Releases
FDA Approval for Allegra’s filing for supplemental new drug...
Allergan plc, a leading global pharmaceutical company, and Medicines360, a global nonprofit women's health pharmaceutical company with a mission of expanding access to quality medicines,...
Press Releases
AbbVie and Voyager Therapeutics collaborates for Neurodegenerative Diseases
AbbVie , a global biopharmaceutical company, and Voyager Therapeutics, Inc. , a clinical-stage gene therapy company announced that they have entered into an exclusive strategic...
Press Releases
Astrazeneca’s Imfinzi for unresectable Stage III non-small cell lung...
AstraZeneca and MedImmune, its global biologics research and development arm, today announced that the US FDA has approved Imfinzi for the treatment of patients with...
Press Releases
Allergan Presents Data at the 2018 American Academy of...
The meeting will be held at the San Diego Convention Center and the scheduled times (noted in local Pacific Time) for the Allergan presentations, titles...
Press Releases
Amgen sets up a FDA Advisory Committee Meeting To...
Amgen announced that the Oncologic Drugs Advisory Committee of the U.S. FDA will review data supporting the BLINCYTO® (blinatumomab) supplemental Biologics License Application (sBLA) for...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.